Reawakening atlas: Chemical approaches to repair or replace dysfunctional musculature

ACS Chemical Biology

Volumn 7, Issue 11, 2012, Pages 1773-1790

  Jung, Da Woon ^a   Williams, Darren R ^a  

^a Gwangju Institute of Science and Technology (GIST)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 9 (TETRAHYDRO 2 FURYL)ADENINE; AGENTS ACTING ON THE PERIPHERAL NERVOUS AND NEUROMUSCULAR SYSTEMS; ARCTIGENIN; B 25; BMN 195; CARDIONOGEN; DICKKOPF RELATED PROTEIN 1; GW 1516; LYSOPHOSPHATIDIC ACID; MESODERM POSTERIOR PROTEIN 1; MYOSEVERIN; PROTEIN; RESVERATROL; RETINOIC ACID; REVERSINE; SMTC 1100; TRANSCRIPTION FACTOR NKX2.5; UNCLASSIFIED DRUG; WNT PROTEIN;

CELL DIFFERENTIATION; CELL THERAPY; EMBRYONIC STEM CELL; HEART INFARCTION; HEART MUSCLE CELL; HEART VENTRICLE; HEMATOPOIETIC STEM CELL; HUMAN; MESENCHYMAL STEM CELL; MUSCLE DISEASE; MUSCLE EXERCISE; MUSCLE REGENERATION; MUSCLE STRENGTH; MYOBLAST; MYOTONIC DYSTROPHY; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; SMOOTH MUSCLE FIBER;

ANIMALS; CELL DIFFERENTIATION; HEART DISEASES; HUMANS; MUSCLES; MUSCULAR DISEASES; REGENERATION; REGENERATIVE MEDICINE; SMALL MOLECULE LIBRARIES; TISSUE THERAPY;

SALAMANDROIDEA;

EID: 84869386452     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb3003368     Document Type: Review

References (182)

1. World Health Organization (2004) Annex Table 2: Deaths by cause, sex and mortality stratum in WHO regions, estimates for 2002, in The world health report 2004-changing history.
2. Conte, G. (2003) Degeneration (scrofula) of the skeletal muscle system. 1836 Acta Myol. 22, 70-89
3. Stanley, W. C., Shah, K. B., and Essop, M. F. (2009) Does junk food lead to heart failure? Importance of dietary macronutrient composition in hypertension Hypertension 54, 1209-1210
4. Franchini, M. and Mannucci, P. M. (2012) Air pollution and cardiovascular disease Thromb. Res. 129, 230-234
5. Lin, R. T., Chen, Y. M., Chien, L. C., and Chan, C. C. (2012) Political and social determinants of life expectancy in less developed countries: a longitudinal study BMC Public Health 12, 85
6. Lang, T., Streeper, T., Cawthon, P., Baldwin, K., Taaffe, D. R., and Harris, T. B. (2010) Sarcopenia: etiology, clinical consequences, intervention, and assessment Osteoporosis Int. 21, 543-559
7. Mason, C., Brindley, D. A., Culme-Seymour, E. J., and Davie, N. L. (2011) Cell therapy industry: billion dollar global business with unlimited potential Regen. Med. 6, 265-272
8. Thomas, E. D., Lochte, H. L., Jr., Lu, W. C., and Ferrebee, J. W. (1957) Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy N. Engl. J. Med. 257, 491-496
9. Gratwohl, A., Baldomero, H., Aljurf, M., Pasquini, M. C., Bouzas, L. F., Yoshimi, A., Szer, J., Lipton, J., Schwendener, A., Gratwohl, M., Frauendorfer, K., Niederwieser, D., Horowitz, M., and Kodera, Y. (2010) Hematopoietic stem cell transplantation: a global perspective J. Am. Med. Assoc. 303, 1617-1624
10. Gersh, B. J., Simari, R. D., Behfar, A., Terzic, C. M., and Terzic, A. (2009) Cardiac cell repair therapy: a clinical perspective Mayo Clin. Proc. 84, 876-892
11. Shadrach, J. L. and Wagers, A. J. (2011) Stem cells for skeletal muscle repair Philos. Trans. R. Soc., B 366, 2297-2306
12. de Villiers, J. A., Houreld, N., and Abrahamse, H. (2009) Adipose derived stem cells and smooth muscle cells: implications for regenerative medicine Stem Cell Rev. 5, 256-265
13. Guillot, P. V., O'Donoghue, K., Kurata, H., and Fisk, N. M. (2006) Fetal stem cells: betwixt and between Semin. Reprod. Med. 24, 340-347
14. Parolini, O., Soncini, M., Evangelista, M., and Schmidt, D. (2009) Amniotic membrane and amniotic fluid-derived cells: potential tools for regenerative medicine? Regen. Med. 4, 275-291
15. Pessina, A. and Gribaldo, L. (2006) The key role of adult stem cells: therapeutic perspectives Curr. Med. Res. Opin. 22, 2287-2300
16. Jung, Y., Bauer, G., and Nolta, J. A. (2012) Concise review: Induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products Stem Cells 30, 42-47
17. Kitsberg, D. (2007) Human embryonic stem cells for tissue engineering Methods Mol. Med. 140, 33-65
18. Takahashi, K. and Yamanaka, S. (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126, 663-676
19. Efe, J. A. and Ding, S. (2011) The evolving biology of small molecules: controlling cell fate and identity Philos. Trans. R. Soc., B 366, 2208-2221
20. Zhu, S., Li, W., Zhou, H., Wei, W., Ambasudhan, R., Lin, T., Kim, J., Zhang, K., and Ding, S. (2010) Reprogramming of human primary somatic cells by OCT4 and chemical compounds Cell Stem Cell 7, 651-655
21. Li, Y. Q. (2010) Master stem cell transcription factors and signaling regulation Cell. Reprogramming 12, 3-13
22. Jung, D. W., Kim, J., Che, Z. M., Oh, E. S., Kim, G., Eom, S. H., Im, S. H., Ha, H. H., Chang, Y. T., and Williams, D. R. (2011) A triazine compound S06 inhibits proinvasive crosstalk between carcinoma cells and stromal fibroblasts via binding to heat shock protein 90 Chem. Biol. 18, 1581-1590
23. Williams, D., Jung, D. W., Khersonsky, S. M., Heidary, N., Chang, Y. T., and Orlow, S. J. (2004) Identification of compounds that bind mitochondrial F1F0 ATPase by screening a triazine library for correction of albinism Chem. Biol. 11, 1251-1259
24. Min, J., Kyung Kim, Y., Cipriani, P. G., Kang, M., Khersonsky, S. M., Walsh, D. P., Lee, J. Y., Niessen, S., Yates, J. R., 3rd, Gunsalus, K., Piano, F., and Chang, Y. T. (2007) Forward chemical genetic approach identifies new role for GAPDH in insulin signaling Nat. Chem. Biol. 3, 55-59
25. Xu, Y., Shi, Y., and Ding, S. (2008) A chemical approach to stem-cell biology and regenerative medicine Nature 453, 338-344
26. Li, W., Jiang, K., and Ding, S. (2011) Concise review: a chemical approach to control cell fate and function Stem Cells 30, 61-68
27. Li, W. and Ding, S. (2010) Small molecules that modulate embryonic stem cell fate and somatic cell reprogramming Trends Pharmacol. Sci. 31, 36-45
28. Bergmann, O., Bhardwaj, R. D., Bernard, S., Zdunek, S., Barnabe-Heider, F., Walsh, S., Zupicich, J., Alkass, K., Buchholz, B. A., Druid, H., Jovinge, S., and Frisen, J. (2009) Evidence for cardiomyocyte renewal in humans Science 324, 98-102
29. Stamm, C., Lüders, C., Nasseri, B., and Hetzer, R. (2009) Fundamentals of Tissue Engineering and Regenerative Medicine (Meyer, U., Meyer, T., Handschel, J., and Weismann, H. P., Eds.) 1 st ed., pp 441-452, Springer-Verlag, Berlin.
30. Habib, M., Shapira-Schweitzer, K., Caspi, O., Gepstein, A., Arbel, G., Aronson, D., Seliktar, D., and Gepstein, L. (2011) A combined cell therapy and in-situ tissue-engineering approach for myocardial repair Biomaterials 32, 7514-7523
31. Schreiber, S. L. (1998) Chemical genetics resulting from a passion for synthetic organic chemistry Bioorg. Med. Chem. 6, 1127-1152
32. Ramstrom, O., Bunyapaiboonsri, T., Lohmann, S., and Lehn, J. M. (2002) Chemical biology of dynamic combinatorial libraries Biochim. Biophys. Acta 1572, 178-186
33. Martin, A. B. and Schultz, P. G. (1999) Opportunities at the interface of chemistry and biology Trends Cell Biol. 9, M24-28
34. Entzeroth, M. (2003) Emerging trends in high-throughput screening Curr. Opin. Pharmacol. 3, 522-529
35. Hertzberg, R. P. and Pope, A. J. (2000) High-throughput screening: new technology for the 21st century Curr. Opin. Chem. Biol. 4, 445-451
36. McBurney, M. W., Jones-Villeneuve, E. M., Edwards, M. K., and Anderson, P. J. (1982) Control of muscle and neuronal differentiation in a cultured embryonal carcinoma cell line Nature 299, 165-167
37. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., and Jones, J. M. (1998) Embryonic stem cell lines derived from human blastocysts Science 282, 1145-1147
38. Lopez-Sanchez, C. and Garcia-Martinez, V. (2011) Molecular determinants of cardiac specification Cardiovasc. Res. 91, 185-195
39. Buckingham, M., Meilhac, S., and Zaffran, S. (2005) Building the mammalian heart from two sources of myocardial cells Nat. Rev. Genet. 6, 826-835
40. Burridge, P. W., Keller, G., Gold, J. D., and Wu, J. C. (2012) Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming Cell Stem Cell 10, 16-28
41. Bondue, A., Lapouge, G., Paulissen, C., Semeraro, C., Iacovino, M., Kyba, M., and Blanpain, C. (2008) Mesp1 acts as a master regulator of multipotent cardiovascular progenitor specification Cell Stem Cell 3, 69-84
42. Willems, E., Spiering, S., Davidovics, H., Lanier, M., Xia, Z., Dawson, M., Cashman, J., and Mercola, M. (2011) Small-molecule inhibitors of the Wnt pathway potently promote cardiomyocytes from human embryonic stem cell-derived mesoderm Circ. Res. 109, 360-364
43. Ren, Y., Lee, M. Y., Schliffke, S., Paavola, J., Amos, P. J., Ge, X., Ye, M., Zhu, S., Senyei, G., Lum, L., Ehrlich, B. E., and Qyang, Y. (2011) Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells J. Mol. Cell. Cardiol. 51, 280-287
44. Murry, C. E. and Keller, G. (2008) Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development Cell 132, 661-680
45. Wang, H., Hao, J., and Hong, C. C. (2011) Cardiac induction of embryonic stem cells by a small molecule inhibitor of Wnt/beta-catenin signaling ACS Chem. Biol. 6, 192-197
46. Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M., Field, L. J., and Keller, G. M. (2008) Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population Nature 453, 524-528
47. Kattman, S. J., Witty, A. D., Gagliardi, M., Dubois, N. C., Niapour, M., Hotta, A., Ellis, J., and Keller, G. (2011) Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines Cell Stem Cell 8, 228-240
48. Uosaki, H., Fukushima, H., Takeuchi, A., Matsuoka, S., Nakatsuji, N., Yamanaka, S., and Yamashita, J. K. (2011) Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression PLoS One 6, e23657
49. Zhang, J., Wilson, G. F., Soerens, A. G., Koonce, C. H., Yu, J., Palecek, S. P., Thomson, J. A., and Kamp, T. J. (2009) Functional cardiomyocytes derived from human induced pluripotent stem cells Circ. Res. 104, e30-41
50. Kempf, H., Lecina, M., Ting, S., Zweigerdt, R., and Oh, S. (2011) Distinct regulation of mitogen-activated protein kinase activities is coupled with enhanced cardiac differentiation of human embryonic stem cells Stem Cell Res 7, 198-209
51. Martin, M. J., Muotri, A., Gage, F., and Varki, A. (2005) Human embryonic stem cells express an immunogenic nonhuman sialic acid Nat. Med. 11, 228-232
52. Ortel, T. L., Mercer, M. C., Thames, E. H., Moore, K. D., and Lawson, J. H. (2001) Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin Ann. Surg. 233, 88-96
53. Naito, A. T., Shiojima, I., Akazawa, H., Hidaka, K., Morisaki, T., Kikuchi, A., and Komuro, I. (2006) Developmental stage-specific biphasic roles of Wnt/beta-catenin signaling in cardiomyogenesis and hematopoiesis Proc. Natl. Acad. Sci. U.S.A. 103, 19812-19817
54. Hug, K. and Hermeren, G. (2011) Do we still need human embryonic stem cells for stem cell-based therapies? Epistemic and ethical aspects Stem Cell Rev 7, 761-774
55. Zhao, T., Zhang, Z. N., Rong, Z., and Xu, Y. (2011) Immunogenicity of induced pluripotent stem cells Nature 474, 212-215
56. Makino, S., Fukuda, K., Miyoshi, S., Konishi, F., Kodama, H., Pan, J., Sano, M., Takahashi, T., Hori, S., Abe, H., Hata, J., Umezawa, A., and Ogawa, S. (1999) Cardiomyocytes can be generated from marrow stromal cells in vitro J. Clin. Invest. 103, 697-705
57. Yau, W. W., Tang, M. K., Chen, E., Yaoyao, Wong, I. W., Lee, H. S., and Lee, K. (2011) Cardiogenol C can induce mouse hair bulge progenitor cells to transdifferentiate into cardiomyocyte-like cells Proteome Sci. 9, 3
58. Sadek, H., Hannack, B., Choe, E., Wang, J., Latif, S., Garry, M. G., Garry, D. J., Longgood, J., Frantz, D. E., Olson, E. N., Hsieh, J., and Schneider, J. W. (2008) Cardiogenic small molecules that enhance myocardial repair by stem cells Proc. Natl. Acad. Sci. U.S.A. 105, 6063-6068
59. Mauro, A. (1961) Satellite cell of skeletal muscle fibers J. Biophys. Biochem. Cytol. 9, 493-495
60. Menasche, P., Hagege, A. A., Vilquin, J. T., Desnos, M., Abergel, E., Pouzet, B., Bel, A., Sarateanu, S., Scorsin, M., Schwartz, K., Bruneval, P., Benbunan, M., Marolleau, J. P., and Duboc, D. (2003) Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction J. Am. Coll. Cardiol. 41, 1078-1083
61. Menasche, P., Alfieri, O., Janssens, S., McKenna, W., Reichenspurner, H., Trinquart, L., Vilquin, J. T., Marolleau, J. P., Seymour, B., Larghero, J., Lake, S., Chatellier, G., Solomon, S., Desnos, M., and Hagege, A. A. (2008) The myoblast autologous grafting in ischemic cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation Circulation 117, 1189-1200
62. Pasha, Z., Haider, H., and Ashraf, M. (2011) Efficient non-viral reprogramming of myoblasts to stemness with a single small molecule to generate cardiac progenitor cells PLoS One 6, e23667
63. Dai, W. and Kloner, R. A. (2011) Bone marrow-derived cell transplantation therapy for myocardial infarction: lessons learned and future questions Am J. Transplant. 11, 2297-2301
64. Shinmura, D., Togashi, I., Miyoshi, S., Nishiyama, N., Hida, N., Tsuji, H., Tsuruta, H., Segawa, K., Tsukada, Y., Ogawa, S., and Umezawa, A. (2011) Pretreatment of human mesenchymal stem cells with pioglitazone improved efficiency of cardiomyogenic transdifferentiation and cardiac function Stem Cells 29, 357-366
65. Gilbertson, J. (1977) Cardiac Muscle in Lipid Metabolism in Mammals, Plenium Press, New York.
66. Takeda, Y., Mori, T., Imabayashi, H., Kiyono, T., Gojo, S., Miyoshi, S., Hida, N., Ita, M., Segawa, K., Ogawa, S., Sakamoto, M., Nakamura, S., and Umezawa, A. (2004) Can the life span of human marrow stromal cells be prolonged by bmi-1, E6, E7, and/or telomerase without affecting cardiomyogenic differentiation? J. Gene Med. 6, 833-845
67. Zhou, B., Honor, L. B., He, H., Ma, Q., Oh, J. H., Butterfield, C., Lin, R. Z., Melero-Martin, J. M., Dolmatova, E., Duffy, H. S., Gise, A., Zhou, P., Hu, Y. W., Wang, G., Zhang, B., Wang, L., Hall, J. L., Moses, M. A., McGowan, F. X., and Pu, W. T. (2011) Adult mouse epicardium modulates myocardial injury by secreting paracrine factors J. Clin. Invest. 121, 1894-1904
68. Russell, J. L., Goetsch, S. C., Aguilar, H. R., Frantz, D. E., and Schneider, J. W. (2012) Targeting native adult heart progenitors with cardiogenic small molecules ACS Chem. Biol. 7, 1067-1076
69. Kwon, C., Qian, L., Cheng, P., Nigam, V., Arnold, J., and Srivastava, D. (2009) A regulatory pathway involving Notch1/beta-catenin/Isl1 determines cardiac progenitor cell fate Nat. Cell Biol. 11, 951-957
70. Russell, J. L., Goetsch, S. C., Aguilar, H. R., Coe, H., Luo, X., Liu, N., van Rooij, E., Frantz, D. E., and Schneider, J. W. (2012) Regulated expression of pH sensing G protein-coupled receptor-68 identified through chemical biology defines a new drug target for ischemic heart disease ACS Chem. Biol. 7, 1077-1083
71. Kari, G., Rodeck, U., and Dicker, A. P. (2007) Zebrafish: an emerging model system for human disease and drug discovery Clin. Pharmacol. Ther. 82, 70-80
72. Khersonsky, S. M., Jung, D. W., Kang, T. W., Walsh, D. P., Moon, H. S., Jo, H., Jacobson, E. M., Shetty, V., Neubert, T. A., and Chang, Y. T. (2003) Facilitated forward chemical genetics using a tagged triazine library and zebrafish embryo screening J. Am. Chem. Soc. 125, 11804-11805
73. Dahme, T., Katus, H. A., and Rottbauer, W. (2009) Fishing for the genetic basis of cardiovascular disease Dis. Models & Mech. 2, 18-22
74. Ni, T. T., Rellinger, E. J., Mukherjee, A., Xie, S., Stephens, L., Thorne, C. A., Kim, K., Hu, J., Lee, E., Marnett, L., Hatzopoulos, A. K., and Zhong, T. P. (2011) Discovering small molecules that promote cardiomyocyte generation by modulating Wnt signaling Chem. Biol. 18, 1658-1668
75. Zaruba, M. M., Theiss, H. D., Vallaster, M., Mehl, U., Brunner, S., David, R., Fischer, R., Krieg, L., Hirsch, E., Huber, B., Nathan, P., Israel, L., Imhof, A., Herbach, N., Assmann, G., Wanke, R., Mueller-Hoecker, J., Steinbeck, G., and Franz, W. M. (2009) Synergy between CD26/DPP-IV inhibition and G-CSF improves cardiac function after acute myocardial infarction Cell Stem Cell 4, 313-323
76. Ko, S. K., Jin, H. J., Jung, D. W., Tian, X., and Shin, I. (2009) Cardiosulfa, a small molecule that induces abnormal heart development in zebrafish, and its biological implications Angew. Chem., Int. Ed. 48, 7809-7812
77. Wang, Y., Zhong, T., Qian, L., Dong, Y., Jiang, Q., Tan, L., and Song, H. (2005) Wortmannin induces zebrafish cardia bifida through a mechanism independent of phosphoinositide 3-kinase and myosin light chain kinase Biochem. Biophys. Res. Commun. 331, 303-308
78. Theiss, H. D., Vallaster, M., Rischpler, C., Krieg, L., Zaruba, M. M., Brunner, S., Vanchev, Y., Fischer, R., Grobner, M., Huber, B., Wollenweber, T., Assmann, G., Mueller-Hoecker, J., Hacker, M., and Franz, W. M. (2011) Dual stem cell therapy after myocardial infarction acts specifically by enhanced homing via the SDF-1/CXCR4 axis Stem Cell Res 7, 244-255
79. Elaine, M. and Hoehn, K. (2007) Human Anatomy & Physiology, 7 ed., Pearson Benjamin Cummings, San Francisco.
80. Mouly, V., Aamiri, A., Perie, S., Mamchaoui, K., Barani, A., Bigot, A., Bouazza, B., Francois, V., Furling, D., Jacquemin, V., Negroni, E., Riederer, I., Vignaud, A., St, Guily, J. L., and Butler-Browne, G. S. (2005) Myoblast transfer therapy: is there any light at the end of the tunnel? Acta Myol. 24, 128-133
81. Partridge, T. A. (2011) Impending therapies for Duchenne muscular dystrophy Curr. Opin. Neurol. 24, 415-422
82. Boldrin, L. and Morgan, J. E. (2007) Activating muscle stem cells: therapeutic potential in muscle diseases Curr. Opin. Neurol. 20, 577-582
83. Narkar, V. A., Downes, M., Yu, R. T., Embler, E., Wang, Y. X., Banayo, E., Mihaylova, M. M., Nelson, M. C., Zou, Y., Juguilon, H., Kang, H., Shaw, R. J., and Evans, R. M. (2008) AMPK and PPARdelta agonists are exercise mimetics Cell 134, 405-415
84. Tang, X., Zhuang, J., Chen, J., Yu, L., Hu, L., Jiang, H., and Shen, X. (2011) Arctigenin efficiently enhanced sedentary mice treadmill endurance PLoS One 6, e24224
85. Lagouge, M., Argmann, C., Gerhart-Hines, Z., Meziane, H., Lerin, C., Daussin, F., Messadeq, N., Milne, J., Lambert, P., Elliott, P., Geny, B., Laakso, M., Puigserver, P., and Auwerx, J. (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha Cell 127, 1109-1122
86. Matsakas, A. and Narkar, V. A. (2010) Endurance exercise mimetics in skeletal muscle Curr. Sports Med. Rep. 9, 227-232
87. Houtkooper, R. H., Pirinen, E., and Auwerx, J. (2012) Sirtuins as regulators of metabolism and healthspan Nat. Rev. Mol. Cell Biol. 13, 225-238
88. Olesen, J., Kiilerich, K., and Pilegaard, H. (2010) PGC-1alpha-mediated adaptations in skeletal muscle Pflugers Arch. 460, 153-162
89. Pilegaard, H., Saltin, B., and Neufer, P. D. (2003) Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle J. Physiol. 546, 851-858
90. Beytia Mde, L., Vry, J., and Kirschner, J. (2012) Drug treatment of Duchenne muscular dystrophy: available evidence and perspectives Acta Myol. 31, 4-8
91. Koenig, M., Hoffman, E. P., Bertelson, C. J., Monaco, A. P., Feener, C., and Kunkel, L. M. (1987) Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals Cell 50, 509-517
92. Bertorini, T. E., Bhattacharya, S. K., Palmieri, G. M., Chesney, C. M., Pifer, D., and Baker, B. (1982) Muscle calcium and magnesium content in Duchenne muscular dystrophy Neurology 32, 1088-1092
93. Moser, H. (1984) Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention Hum. Genet. 66, 17-40
94. Goemans, N., Tulinius, M., Buyse, G., Wilson, R., and Kimpe, R. d. (2010) 24 week follow-up data from a phase I/IIa extension study of PRO051/GSK2402968 in subjects with Duchenne muscular dystrophy Neuromusc. Disord. 20, 639
95. Calcedo, R., Vandenberghe, L. H., Gao, G., Lin, J., and Wilson, J. M. (2009) Worldwide epidemiology of neutralizing antibodies to adeno-associated viruses J. Infect. Dis. 199, 381-390
96. Lin, S. and Burgunder, J. M. (2000) Utrophin may be a precursor of dystrophin during skeletal muscle development Brain Res. Dev. Brain Res. 119, 289-295
97. Tinsley, J., Deconinck, N., Fisher, R., Kahn, D., Phelps, S., Gillis, J. M., and Davies, K. (1998) Expression of full-length utrophin prevents muscular dystrophy in mdx mice Nat. Med. 4, 1441-1444
98. Tinsley, J. M., Fairclough, R. J., Storer, R., Wilkes, F. J., Potter, A. C., Squire, S. E., Powell, D. S., Cozzoli, A., Capogrosso, R. F., Lambert, A., Wilson, F. X., Wren, S. P., De Luca, A., and Davies, K. E. (2011) Daily treatment with SMTC1100, a novel small molecule utrophin upregulator, dramatically reduces the dystrophic symptoms in the mdx mouse PLoS One 6, e19189
99. Nelson, S. F., Crosbie, R. H., Miceli, M. C., and Spencer, M. J. (2009) Emerging genetic therapies to treat Duchenne muscular dystrophy Curr. Opin. Neurol. 22, 532-538
100. Turner, C. and Hilton-Jones, D. (2010) The myotonic dystrophies: diagnosis and management J. Neurol. Neurosurg. Psych. 81, 358-367
101. Philips, A. V., Timchenko, L. T., and Cooper, T. A. (1998) Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy Science 280, 737-741
102. Mankodi, A., Takahashi, M. P., Jiang, H., Beck, C. L., Bowers, W. J., Moxley, R. T., Cannon, S. C., and Thornton, C. A. (2002) Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy Mol. Cell 10, 35-44
103. Savkur, R. S., Philips, A. V., and Cooper, T. A. (2001) Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy Nat. Genet. 29, 40-47
104. Warf, M. B., Nakamori, M., Matthys, C. M., Thornton, C. A., and Berglund, J. A. (2009) Pentamidine reverses the splicing defects associated with myotonic dystrophy Proc. Natl. Acad. Sci. U.S.A. 106, 18551-18556
105. Pushechnikov, A., Lee, M. M., Childs-Disney, J. L., Sobczak, K., French, J. M., Thornton, C. A., and Disney, M. D. (2009) Rational design of ligands targeting triplet repeating transcripts that cause RNA dominant disease: application to myotonic muscular dystrophy type 1 and spinocerebellar ataxia type 3 J. Am. Chem. Soc. 131, 9767-9779
106. Parkesh, R., Childs-Disney, J. L., Nakamori, M., Kumar, A., Wang, E., Wang, T., Hoskins, J., Tran, T., Housman, D., Thornton, C. A., and Disney, M. D. (2012) Design of a bioactive small molecule that targets the myotonic dystrophy type 1 RNA via an RNA motif-ligand database and chemical similarity searching J. Am. Chem. Soc. 134, 4731-4742
107. Campion, D. R. (1984) The muscle satellite cell: a review Int. Rev. Cytol. 87, 225-251
108. Scharner, J. and Zammit, P. S. (2011) The muscle satellite cell at 50: the formative years Skeletal Muscle 1, 28
109. Thornell, L. E. (2011) Sarcopenic obesity: satellite cells in the aging muscle Curr. Opin. Clin. Nutr. Metab. Care 14, 22-27
110. Brockes, J. P. and Kumar, A. (2008) Comparative aspects of animal regeneration Annu. Rev. Cell Dev. Biol. 24, 525-549
111. Tweedell, K. S. (2010) The urodele limb regeneration blastema: the cell potential Sci. World J. 10, 954-971
112. Mu, X., Peng, H., Pan, H., Huard, J., and Li, Y. (2011) Study of muscle cell dedifferentiation after skeletal muscle injury of mice with a Cre-Lox system PLoS One 6, e16699
113. Brockes, J. P. and Lo, D. C. (1994) Reversibility of the mononucleate-to-multinucleate myogenic transition during amphibian limb regeneration Eye (London) 8 (Pt 2) 151-154
114. Endo, T. (2007) Stem cells and plasticity of skeletal muscle cell differentiation: potential application to cell therapy for degenerative muscular diseases Regen. Med. 2, 243-256
115. Odelberg, S. J., Kollhoff, A., and Keating, M. T. (2000) Dedifferentiation of mammalian myotubes induced by msx1 Cell 103, 1099-1109
116. Hjiantoniou, E., Anayasa, M., Nicolaou, P., Bantounas, I., Saito, M., Iseki, S., Uney, J. B., and Phylactou, L. A. (2008) Twist induces reversal of myotube formation Differentiation 76, 182-192
117. Mastroyiannopoulos, N. P., Nicolaou, P., Anayasa, M., Uney, J. B., and Phylactou, L. A. (2012) Down-regulation of myogenin can reverse terminal muscle cell differentiation PLoS One 7, e29896
118. Kim, W. H., Jung, D. W., Kim, J., Im, S. H., Hwang, S. Y., and Williams, D. R. (2012) Small molecules that recapitulate the early steps of urodele amphibian limb regeneration and confer multipotency ACS Chem. Biol. 7, 732-743
119. Jung, D. W. and Williams, D. R. (2011) Novel chemically defined approach to produce multipotent cells from terminally differentiated tissue syncytia ACS Chem. Biol. 6, 553-562
120. Paliwal, P. and Conboy, I. M. (2011) Inhibitors of tyrosine phosphatases and apoptosis reprogram lineage-marked differentiated muscle to myogenic progenitor cells Chem. Biol. 18, 1153-1166
121. Perez, O. D., Chang, Y. T., Rosania, G., Sutherlin, D., and Schultz, P. G. (2002) Inhibition and reversal of myogenic differentiation by purine-based microtubule assembly inhibitors Chem. Biol. 9, 475-483
122. Jung, D. W., Ha, H. H., Zheng, X., Chang, Y. T., and Williams, D. R. (2011) Novel use of fluorescent glucose analogues to identify a new class of triazine-based insulin mimetics possessing useful secondary effects Mol. Biosyst. 7, 346-358
123. Jung, D. W., Williams, D., Khersonsky, S. M., Kang, T. W., Heidary, N., Chang, Y. T., and Orlow, S. J. (2005) Identification of the F1F0 mitochondrial ATPase as a target for modulating skin pigmentation by screening a tagged triazine library in zebrafish Mol. Biosyst. 1, 85-92
124. Christen, B., Robles, V., Raya, M., Paramonov, I., and Belmonte, J. C. (2010) Regeneration and reprogramming compared BMC Biol. 8, 5
125. Agrawal, V., Johnson, S. A., Reing, J., Zhang, L., Tottey, S., Wang, G., Hirschi, K. K., Braunhut, S., Gudas, L. J., and Badylak, S. F. (2010) Epimorphic regeneration approach to tissue replacement in adult mammals Proc. Natl. Acad. Sci. U.S.A. 107, 3351-3355
126. Endo, T. and Nadal-Ginard, B. (1998) Reversal of myogenic terminal differentiation by SV40 large T antigen results in mitosis and apoptosis J. Cell Sci. 111 (Pt 8) 1081-1093
127. Prosser, C. L. (1974) Smooth muscle Annu. Rev. Physiol. 36, 503-535
128. Staack, A. and Rodriguez, L. V. (2011) Stem cells for the treatment of urinary incontinence Curr. Urol. Rep. 12, 41-46
129. Levy, R. and Muller, N. (2006) Urinary incontinence: economic burden and new choices in pharmaceutical treatment Adv. Ther. 23, 556-573
130. Lifford, K. L., Townsend, M. K., Curhan, G. C., Resnick, N. M., and Grodstein, F. (2008) The epidemiology of urinary incontinence in older women: incidence, progression, and remission J. Am. Geriatr. Soc. 56, 1191-1198
131. Steinbach, S. K., El-Mounayri, O., DaCosta, R. S., Frontini, M. J., Nong, Z., Maeda, A., Pickering, J. G., Miller, F. D., and Husain, M. (2011) Directed differentiation of skin-derived precursors into functional vascular smooth muscle cells Arterioscler., Thromb., Vasc. Biol. 31, 2938-2948
132. Takahashi, T., Lord, B., Schulze, P. C., Fryer, R. M., Sarang, S. S., Gullans, S. R., and Lee, R. T. (2003) Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes Circulation 107, 1912-1916
133. Narita, Y., Yamawaki, A., Kagami, H., Ueda, M., and Ueda, Y. (2008) Effects of transforming growth factor-beta 1 and ascorbic acid on differentiation of human bone-marrow-derived mesenchymal stem cells into smooth muscle cell lineage Cell Tissue Res. 333, 449-459
134. Kolodziejska, K. M., Noyan-Ashraf, M. H., Nagy, A., Bacon, A., Frampton, J., Xin, H. B., Kotlikoff, M. I., and Husain, M. (2008) c-Myb-dependent smooth muscle cell differentiation Circ. Res. 102, 554-561
135. Drab, M., Haller, H., Bychkov, R., Erdmann, B., Lindschau, C., Haase, H., Morano, I., Luft, F. C., and Wobus, A. M. (1997) From totipotent embryonic stem cells to spontaneously contracting smooth muscle cells: a retinoic acid and db-cAMP in vitro differentiation model FASEB J. 11, 905-915
136. Fu, Q., Song, X. F., Liao, G. L., Deng, C. L., and Cui, L. (2010) Myoblasts differentiated from adipose-derived stem cells to treat stress urinary incontinence Urology 75, 718-723
137. Wu, G., Zheng, X., Jiang, Z., Wang, J., and Song, Y. (2010) Induced differentiation of adipose-derived stromal cells into myoblasts J. Huazhong Univ. Sci. Technol., Med. Sci. 30, 285-290
138. Kim, H. J., Ham, S. A., Paek, K. S., Hwang, J. S., Jung, S. Y., Kim, M. Y., Jin, H., Kang, E. S., Woo, I. S., Lee, J. H., Chang, K. C., Han, C. W., and Seo, H. G. (2011) Transcriptional up-regulation of antioxidant genes by PPARdelta inhibits angiotensin II-induced premature senescence in vascular smooth muscle cells Biochem. Biophys. Res. Commun. 406, 564-569
139. Cheung, C., Bernardo, A. S., Trotter, M. W., Pedersen, R. A., and Sinha, S. (2012) Generation of human vascular smooth muscle subtypes provides insight into embryological origin-dependent disease susceptibility Nat. Biotechnol. 30, 165-173
140. Majesky, M. W. (2007) Developmental basis of vascular smooth muscle diversity Arterioscler., Thromb., Vasc. Biol. 27, 1248-1258
141. Shen, M. M. (2007) Nodal signaling: developmental roles and regulation Development 134, 1023-1034
142. Inman, G. J., Nicolas, F. J., Callahan, J. F., Harling, J. D., Gaster, L. M., Reith, A. D., Laping, N. J., and Hill, C. S. (2002) SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7 Mol. Pharmacol. 62, 65-74
143. Franke, T. F. (2008) PI3K/Akt: getting it right matters Oncogene 27, 6473-6488
144. Lyssiotis, C. A., Lairson, L. L., Boitano, A. E., Wurdak, H., Zhu, S., and Schultz, P. G. (2011) Chemical control of stem cell fate and developmental potential Angew. Chem., Int. Ed. 50, 200-242
145. Firestone, A. J. and Chen, J. K. (2010) Controlling destiny through chemistry: small-molecule regulators of cell fate ACS Chem. Biol. 5, 15-34
146. Hatanaka, T., Manabe, E., Ohtsuki, T., Okuyama, K., Mori, M., Okada, H., Katayama, K., and Koizumi, T. (2000) Drug targeting efficacy to underlying muscle following topical application. I. Evaluation based on a physiological pharmacokinetic model Biol. Pharm. Bull. 23, 860-865
147. Lee, C. M. and Maibach, H. I. (2006) Deep percutaneous penetration into muscles and joints J. Pharm. Sci. 95, 1405-1413
148. Schnyder, A., Krahenbuhl, S., Torok, M., Drewe, J., and Huwyler, J. (2004) Targeting of skeletal muscle in vitro using biotinylated immunoliposomes Biochem. J. 377, 61-67
149. Nag, A. C. (1980) Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution Cytobios 28, 41-61
150. Zimmermann, W. H., Didie, M., Wasmeier, G. H., Nixdorff, U., Hess, A., Melnychenko, I., Boy, O., Neuhuber, W. L., Weyand, M., and Eschenhagen, T. (2002) Cardiac grafting of engineered heart tissue in syngenic rats Circulation 106, I151-157
151. Zimmermann, W. H., Melnychenko, I., Wasmeier, G., Didie, M., Naito, H., Nixdorff, U., Hess, A., Budinsky, L., Brune, K., Michaelis, B., Dhein, S., Schwoerer, A., Ehmke, H., and Eschenhagen, T. (2006) Engineered heart tissue grafts improve systolic and diastolic function in infarcted rat hearts Nat. Med. 12, 452-458
152. Furuta, A., Miyoshi, S., Itabashi, Y., Shimizu, T., Kira, S., Hayakawa, K., Nishiyama, N., Tanimoto, K., Hagiwara, Y., Satoh, T., Fukuda, K., Okano, T., and Ogawa, S. (2006) Pulsatile cardiac tissue grafts using a novel three-dimensional cell sheet manipulation technique functionally integrates with the host heart, in vivo Circ. Res. 98, 705-712
153. Haraguchi, Y., Shimizu, T., Yamato, M., Kikuchi, A., and Okano, T. (2006) Electrical coupling of cardiomyocyte sheets occurs rapidly via functional gap junction formation Biomaterials 27, 4765-4774
154. Liau, B., Christoforou, N., Leong, K. W., and Bursac, N. (2011) Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function Biomaterials 32, 9180-9187
155. Dvir, T., Timko, B. P., Brigham, M. D., Naik, S. R., Karajanagi, S. S., Levy, O., Jin, H., Parker, K. K., Langer, R., and Kohane, D. S. (2011) Nanowired three-dimensional cardiac patches Nat. Nanotechnol. 6, 720-725
156. Dambrot, C., Passier, R., Atsma, D., and Mummery, C. L. (2011) Cardiomyocyte differentiation of pluripotent stem cells and their use as cardiac disease models Biochem. J. 434, 25-35
157. Elliott, D. A., Braam, S. R., Koutsis, K., Ng, E. S., Jenny, R., Lagerqvist, E. L., Biben, C., Hatzistavrou, T., Hirst, C. E., Yu, Q. C., Skelton, R. J., Ward-van Oostwaard, D., Lim, S. M., Khammy, O., Li, X., Hawes, S. M., Davis, R. P., Goulburn, A. L., Passier, R., Prall, O. W., Haynes, J. M., Pouton, C. W., Kaye, D. M., Mummery, C. L., Elefanty, A. G., and Stanley, E. G. (2011) NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes Nat. Methods 8, 1037-1040
158. Hattori, F., Chen, H., Yamashita, H., Tohyama, S., Satoh, Y. S., Yuasa, S., Li, W., Yamakawa, H., Tanaka, T., Onitsuka, T., Shimoji, K., Ohno, Y., Egashira, T., Kaneda, R., Murata, M., Hidaka, K., Morisaki, T., Sasaki, E., Suzuki, T., Sano, M., Makino, S., Oikawa, S., and Fukuda, K. (2010) Nongenetic method for purifying stem cell-derived cardiomyocytes Nat. Methods 7, 61-66
159. Nemir, M., Croquelois, A., Pedrazzini, T., and Radtke, F. (2006) Induction of cardiogenesis in embryonic stem cells via downregulation of Notch1 signaling Circ. Res. 98, 1471-1478
160. Geling, A., Steiner, H., Willem, M., Bally-Cuif, L., and Haass, C. (2002) A gamma-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish EMBO Rep. 3, 688-694
161. Qian, L., Huang, Y., Spencer, C. I., Foley, A., Vedantham, V., Liu, L., Conway, S. J., Fu, J. D., and Srivastava, D. (2012) In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes Nature 485, 593-598
162. Song, K., Nam, Y. J., Luo, X., Qi, X., Tan, W., Huang, G. N., Acharya, A., Smith, C. L., Tallquist, M. D., Neilson, E. G., Hill, J. A., Bassel-Duby, R., and Olson, E. N. (2012) Heart repair by reprogramming non-myocytes with cardiac transcription factors Nature 485, 599-604
163. Burnett, C., Valentini, S., Cabreiro, F., Goss, M., Somogyvari, M., Piper, M. D., Hoddinott, M., Sutphin, G. L., Leko, V., McElwee, J. J., Vazquez-Manrique, R. P., Orfila, A. M., Ackerman, D., Au, C., Vinti, G., Riesen, M., Howard, K., Neri, C., Bedalov, A., Kaeberlein, M., Soti, C., Partridge, L., and Gems, D. (2011) Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila Nature 477, 482-485
164. Jasmin, Spray, D. C., Campos de Carvalho, A. C., and Mendez-Otero, R. (2010) Chemical induction of cardiac differentiation in p19 embryonal carcinoma stem cells Stem Cells Dev. 19, 403-412
165. Choi, S. C., Yoon, J., Shim, W. J., Ro, Y. M., and Lim, D. S. (2004) 5-azacytidine induces cardiac differentiation of P19 embryonic stem cells Ex.p Mol. Med. 36, 515-523
166. He, J. Q., Vu, D. M., Hunt, G., Chugh, A., Bhatnagar, A., and Bolli, R. (2011) Human cardiac stem cells isolated from atrial appendages stably express c-kit PLoS One 6, e27719
167. Wu, X., Ding, S., Ding, Q., Gray, N. S., and Schultz, P. G. (2004) Small molecules that induce cardiomyogenesis in embryonic stem cells J. Am. Chem. Soc. 126, 1590-1591
168. Wei, Z. L., Petukhov, P. A., Bizik, F., Teixeira, J. C., Mercola, M., Volpe, E. A., Glazer, R. I., Willson, T. M., and Kozikowski, A. P. (2004) Isoxazolyl-serine-based agonists of peroxisome proliferator-activated receptor: design, synthesis, and effects on cardiomyocyte differentiation J. Am. Chem. Soc. 126, 16714-16715
169. Sachinidis, A., Schwengberg, S., Hippler-Altenburg, R., Mariappan, D., Kamisetti, N., Seelig, B., Berkessel, A., and Hescheler, J. (2006) Identification of small signalling molecules promoting cardiac-specific differentiation of mouse embryonic stem cells Cell Physiol. Biochem. 18, 303-314
170. Qyang, Y., Martin-Puig, S., Chiravuri, M., Chen, S., Xu, H., Bu, L., Jiang, X., Lin, L., Granger, A., Moretti, A., Caron, L., Wu, X., Clarke, J., Taketo, M. M., Laugwitz, K. L., Moon, R. T., Gruber, P., Evans, S. M., Ding, S., and Chien, K. R. (2007) The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway Cell Stem Cell 1, 165-179
171. Hao, J., Daleo, M. A., Murphy, C. K., Yu, P. B., Ho, J. N., Hu, J., Peterson, R. T., Hatzopoulos, A. K., and Hong, C. C. (2008) Dorsomorphin, a selective small molecule inhibitor of BMP signaling, promotes cardiomyogenesis in embryonic stem cells PLoS One 3, e2904
172. Gaur, M., Ritner, C., Sievers, R., Pedersen, A., Prasad, M., Bernstein, H. S., and Yeghiazarians, Y. (2010) Timed inhibition of p38MAPK directs accelerated differentiation of human embryonic stem cells into cardiomyocytes Cytotherapy 12, 807-817
173. Berkessel, A., Seelig, B., Schwengberg, S., Hescheler, J., and Sachinidis, A. (2010) Chemically induced cardiomyogenesis of mouse embryonic stem cells ChemBioChem 11, 208-217
174. Parsons, X. H., Teng, Y. D., Parsons, J. F., Snyder, E. Y., Smotrich, D. B., and Moore, D. A. (2011) Efficient derivation of human cardiac precursors and cardiomyocytes from pluripotent human embryonic stem cells with small molecule induction J. Visualized Exp. e3274
175. Chen, W. P. and Wu, S. M. (2012) Small molecule regulators of postnatal Nkx2.5 cardiomyoblast proliferation and differentiation J. Cell. Mol. Med. 16, 961-965
176. Efe, J. A., Hilcove, S., Kim, J., Zhou, H., Ouyang, K., Wang, G., Chen, J., and Ding, S. (2011) Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy Nat. Cell Biol. 13, 215-222
177. Pikir, B. S., Susilowati, H., Hendrianto, E., and Abdulrantam, F. (2012) Reversin increase the plasticity of bone marrow-derived mesenchymal stem cell for generation of cardiomyocyte in vitro Acta Med, Indones 44, 23-27
178. Rosania, G. R., Chang, Y. T., Perez, O., Sutherlin, D., Dong, H., Lockhart, D. J., and Schultz, P. G. (2000) Myoseverin, a microtubule-binding molecule with novel cellular effects Nat. Biotechnol. 18, 304-308
179. Chen, S., Zhang, Q., Wu, X., Schultz, P. G., and Ding, S. (2004) Dedifferentiation of lineage-committed cells by a small molecule J. Am. Chem. Soc. 126, 410-411
180. Kennedy, K. A., Porter, T., Mehta, V., Ryan, S. D., Price, F., Peshdary, V., Karamboulas, C., Savage, J., Drysdale, T. A., Li, S. C., Bennett, S. A., and Skerjanc, I. S. (2009) Retinoic acid enhances skeletal muscle progenitor formation and bypasses inhibition by bone morphogenetic protein 4 but not dominant negative beta-catenin BMC Biol, 7, 67
181. Le May, M., Mach, H., Lacroix, N., Hou, C., Chen, J., and Li, Q. (2011) Contribution of retinoid X receptor signaling to the specification of skeletal muscle lineage J. Biol. Chem. 286, 26806-26812
182. Kim, Y. K., Ha, H. H., Lee, J. S., Bi, X., Ahn, Y. H., Hajar, S., Lee, J. J., and Chang, Y. T. (2010) Control of muscle differentiation by a mitochondria-targeted fluorophore J. Am. Chem. Soc. 132, 576-579